Bharat Biotech Covaxin
Bharat Biotech Covaxin News
Bharat Biotech's Covaxin awaits feedback from WHO on Emergency Use Listing
The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet "to be confirmed," according to the update available on WHO website.
Waive off 'clinical trial mode' for Bharat Biotech Covaxin, expert committee of regulator recommends to DCGI
If granted, the request would loosen the stringent conditions under which the vaccine is being administered, and possibly improve public acceptance of the vaccine.
Covaxin jab effective against UK variant of coronavirus, claims study
Covaxin - vaccine developed by Hyderabad-based Bharat Biotech - is effective against UK variants of COVID-19, according to a study on 26 participants, shared by the company on Wednesday.
Flights ferry COVID-19 vaccine to 13 cities ahead of roll out on 16 Jan; preparations on track, says health ministry
India on Tuesday recorded 12,584 new cases of coronavirus, the lowest in around seven months, taking the country's COVID-19 caseload to1,04,79,179, as per the Union health ministry's morning update
After Covaxin, Bharat Biotech to now begin trials for intranasal COVID-19 vaccine from Feb-March
BBV154 (intranasal COVID-19 vaccine), preclinical testing has been completed for toxicology, immunogenicity and challenge studies. These studies have been conducted in the USA and India
Coronavirus News Updates: COVID-19 vaccination dry run at six sites in Uttar Pradesh from 5 January
Coronavirus News Updates: In a statement, the state government said the dry run will start at 10 am in three urban and as many rural sites with a minimum of two sessions
Bharat Biotech underplays adverse event in Covaxin Phase 1 trial as start date for Phase 3 nears
The volunteer, who had no comorbidities, developed viral pneumonitis after being given a dose of the COVAXIN shot.
Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials
The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.
Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan
Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials
Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine
Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.
Coronavirus Updates: BMC sero-survey in three wards shows 57% prevalence of COVID-19 in slums, 16% in other areas
Coronavirus LIVE Updates: The BMC on Tuesday said that a serological surveillance for COVID-19 infection was commissioned by NITI-Aayog, Municipal Corporation of Greater Mumbai and Tata Institute of Fundamental Research.
Scientists caution govt over plans to fast-track 'Made in India' vaccine, COVAXIN
A virologist said that a vaccine normally takes at least 12-18 months to pass all necessary clinical trial phases while the company developing it has just over a month to wrap up everything
COVID-19 vaccine: ICMR urges institutes chosen for Bharat Biotech's COVAXIN to complete recruitment for human trials by 7 July
The ICMR envisages launching the vaccine for public health use by 15 August after completion of all clinical trials, as per a letter to institutions conducting trials.